These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17641867)

  • 1. [New serum markers in prostate carcinoma and their application to artificial neural networks].
    Stephan C; Jung K; Cammann H; Kramer J; Kristiansen G; Loening SA; Lein M
    Urologe A; 2007 Sep; 46(9):1084-6. PubMed ID: 17641867
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosing prostate cancer: getting to the core question.
    Hernandez DJ
    J Urol; 2013 Jul; 190(1):11-2. PubMed ID: 23608039
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostatic specific antigen (PSA).
    Alberti C
    Minerva Urol Nefrol; 1993 Jun; 45(2):83-4. PubMed ID: 7694380
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Utility of Biomarkers in Localized Prostate Cancer.
    Leapman MS; Nguyen HG; Cooperberg MR
    Curr Oncol Rep; 2016 May; 18(5):30. PubMed ID: 27023445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [German Cancer Society e.V. S3 guideline for PSA determination in diagnosis of prostatic carcinoma].
    Rübben H; Schalkhäuser K; Wolff J; Luboldt HJ;
    Onkologie; 2003 Feb; 26(1):88-9. PubMed ID: 12661558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
    Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
    Haese A; Graefen M; Palisaar J; Huland E; Huland H
    Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up, up and away with new markers and PSA.
    Bercovich E
    Urol Int; 2000; 65(2):117-9. PubMed ID: 11025435
    [No Abstract]   [Full Text] [Related]  

  • 9. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
    Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
    J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed?
    Carroll PR
    Urology; 2001 Apr; 57(4):591-3. PubMed ID: 11306354
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for prostate cancer.
    Neal DE; Donovan JL
    Ann Oncol; 1998 Dec; 9(12):1289-92. PubMed ID: 9932157
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Hoeltl W; Müller MM; Lunglmayr G
    J Urol; 2005 Jun; 173(6):2205; author reply 2205-6. PubMed ID: 15879895
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum ceruloplasmin as a marker in prostate cancer.
    Fotiou K; Vaiopoulos G; Lilakos K; Giannopoulos A; Mandalenaki K; Marinos G; Koritsiadis G; Sourdis J; Konstantinidou E; Konstantopoulos K
    Minerva Urol Nefrol; 2007 Dec; 59(4):407-11. PubMed ID: 17947957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PSA-screening: sensible or meaningless?].
    Dubben HH
    Urologe A; 2009 Sep; 48(9):1103; author reply 1103-4. PubMed ID: 19727645
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding mixed messages about prostate specific antigen: biases in the evaluation of cancer biomarkers.
    Ankerst DP; Thompson IM
    J Urol; 2007 Feb; 177(2):426-7. PubMed ID: 17222602
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
    Medvedev VL
    Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
    [No Abstract]   [Full Text] [Related]  

  • 17. PSA screening.
    Cohen S; Schiff S; Kelty P
    Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer: intriguing data on inflammation and prostate cancer.
    Vignozzi L; Maggi M
    Nat Rev Urol; 2014 Jul; 11(7):369-70. PubMed ID: 24980193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer.
    Stephan C; Cammann H; Meyer HA; Lein M; Jung K
    Cancer Lett; 2007 Apr; 249(1):18-29. PubMed ID: 17292541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups.
    Vickers AJ; Vertosick EA; Sjoberg DD
    Eur Urol; 2018 Oct; 74(4):535-536. PubMed ID: 29903434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.